Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GridAI TechnologiesGRDX +1.08%26 5-Year ROIIC % is 40.51 as of Dec. 2025. GuruFocus rates GRDX with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 1,168 Biotechnology companies, GridAI Technologies ranks better than 76.03% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
GridAI Technologies's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 40.51%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for GridAI Technologies's 5-Year ROIIC % or its related term are showing as below:
GRDX's 5-Year ROIIC % is ranked better than 76.03% of 1168
companies
in the Biotechnology industry
Industry Median: -11.255
vs GRDX: 40.51
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
GridAI Technologies 5-Year ROIIC % Related Terms
GridAI Technologies 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for GridAI Technologies's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GRDX vs CELU, NRSN, ZIVO: 5-Year ROIIC % Comparison
For the Biotechnology subindustry, GridAI Technologies's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GridAI Technologies 5-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GridAI Technologies's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where GridAI Technologies's 5-Year ROIIC % falls into.
GridAI Technologies's 5-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -6.6573117 (Dec. 2025) - -26.433 (Dec. 2020) )
/
( 54.484 (Dec. 2025) - 5.663 (Dec. 2020) )
=
19.7756883
/
48.821
=
40.51%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
GridAI Technologies (GRDX) has a 5-Year ROIIC % of 40.51 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on GridAI Technologies and its competitors. According to the industry distribution chart, GridAI Technologies ranks #280 out of 1168 companies in the Biotechnology industry, placing it in the top 24%.
Is GridAI Technologies' 5-Year ROIIC % too high?
GridAI Technologies' current 5-Year ROIIC % is 40.51. Based on the distribution chart, GridAI Technologies ranks #280 out of 1168 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GridAI Technologies has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does GridAI Technologies' 5-Year ROIIC % compare to CELU and NRSN?
According to the Biotechnology industry distribution chart, GridAI Technologies ranks #280 out of 1168 companies for 5-Year ROIIC %. This places GridAI Technologies in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Biotechnology company?
A good 5-Year ROIIC % depends on the Biotechnology industry context. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on GridAI Technologies and its competitors. GridAI Technologies's current 5-Year ROIIC % is 40.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GridAI Technologies stock overvalued right now?
GridAI Technologies (GRDX) has a current 5-Year ROIIC % of 40.51. The current 5-Year ROIIC % is 40.51. GridAI Technologies' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For GridAI Technologies (GRDX), the current 5-Year ROIIC % is 40.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
26GF Score
Get the complete analysis for GRDX
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDX has been successfully added to your 
